ASCO GU: Many kidney cancer patients left out of clinical trial discussions, survey reveals
Older kidney cancer patients also lack understanding of their remission and survival diagnosis.
Homepage
Pipeline Moves: CuraSen’s Parkinson’s disease and MCI asset’s advancement prospects change with Phase I updates
Pipeline Moves: Roche Phase I suspension plummets further study chances in blood cancers
Are you ready? EU’s Clinical Trials Regulation and portal goes live 31 January
Pipeline Moves: Pfizer completes Phase I trial, boosts NASH program
Revealed: pharma leaders in precision, personalised medicine
Trial Activity Snapshot: Did Australia’s “zero-Covid” plan protect clinical trial activity?
Biosimilars: top 10 pharma companies leading the way
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
